Omeros reported $35.07M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Aerie Pharmaceuticals AERI:US $ 124.99M 6.86M
Cytokinetics CYTK:US $ 66.85M 5.01M
Mirati Therapeutics MRTX:US $ 123.57M 20.09M
Omeros OMER:US $ 35.07M 16.72M
Regulus Therapeutics RGLS:US $ 4.7M 0.53M
Sangamo Biosciences SGMO:US $ 118.53M 9.36M
Vital Therapies VTL:US $ 11.46M 0.06M
Xoma XOMA:US $ 7.89M 5.08M